They accomplished real-time measurement of Aβ in human serum at a concentration of 1 pg/mL without requiring labeling, which was lower than the limit of detection for plasma Aβ determined through an enzyme-linked immune sorbent assay. These results imply that the CNT-MESFET biosensors have the potential to serve as a valuable tool for diagnosing Alzheimer's disease at an early stage.